Day: August 14, 2024

Veeco Announces Agreement with IBM to Explore Wet Processing System for Advanced Packaging Applications

Written by Customer Service on August 14, 2024. Posted in Public Companies.

Veeco’s WaferStorm® Wet Processing System to Enable Essential Cleaning Processes in Hybrid Bonding for IBM PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) today announced that IBM selected the WaferStorm® Wet Processing System for Advanced Packaging applications and has entered into a joint development agreement to explore advanced packaging applications using multiple wet processing technologies from Veeco. Under the agreement, the Waferstorm Wet Processing System will be installed at facilities at the Albany NanoTech Complex in Albany, NY, where IBM and other ecosystem partners are driving leading-edge R&D in advanced packaging and chiplet technologies. The WaferStorm system enables crucial hybrid bonding cleaning processes such as resist strip, temporary bonding strip, and pre-bond...

GlobalTech Launches Big Data & AI Center of Excellence in Pakistan

Written by Customer Service on August 14, 2024. Posted in Public Companies.

RENO, Nev., Aug. 14, 2024 (GLOBE NEWSWIRE) — GlobalTech Corporation (OTC: GLTK) proudly announces the launch of its cutting-edge Center of Excellence dedicated to Big Data and artificial intelligence (AI) in Pakistan. This new facility marks a significant milestone in GlobalTech’s ongoing commitment to technological innovation and global market expansion. The state-of-the-art software center, which is expected to be completed by first quarter of 2025, is to be located within the premises of WorldCall Telecom Limited, a subsidiary of GlobalTech Corporation. Dan Green, GlobalTech’s President, commented on this strategic development, “Technology is at the core of GlobalTech’s business strategy, and we have been diligently working to bring this initiative to fruition. As we advance various products toward market readiness,...

Tevogen Bio’s Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund, Appointed Dean of the University of South Florida Health College of Public Health

Written by Customer Service on August 14, 2024. Posted in Public Companies.

WARREN, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holding Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, congratulates Professor Sten Vermund, MD, PhD, Chairperson of Tevogen Bio’s Innovation and Public Health Advisory Board, on being named as the dean of the USF Health College of Public Health, effective January 1, 2025. In addition to his new role at the University of South Florida, Dr. Vermund will continue to serve as the President of the Global Virus Network (GVN), a nonprofit coalition of human and animal virologists from more than 80 centers of excellence in 40 countries. Under his leadership, the GVN is at the forefront of combating future pandemic...

Plants & Goodwin Inc., a Subsidiary of Zefiro Methane Corp., Acquires a Minority Stake in, and Obtains an Exclusive U.S. Patent License from, Winterhawk Well Abandonment Ltd.

Written by Customer Service on August 14, 2024. Posted in Public Companies.

Winterhawk develops innovative technology to optimize oil and gas well casing operations FORT LAUDERDALE, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) — Plants & Goodwin Inc. (“P&G”), a subsidiary of ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”), today announced the acquisition of a minority ownership interest in Winterhawk Well Abandonment Ltd. (“Winterhawk”) for an undisclosed amount. Winterhawk is a Calgary-based manufacturer of specialized downhole tools and technologies designed to expand casing in oil and gas wells to seal the leak pathways of surface casing vent flows. Sealing these methane leaks using conventional well decommissioning procedures is not always successful, but forward-thinking innovations patented by companies like Winterhawk can increase well...

Tenable Recognized as the Top Performer in Cloud Security by CRN 2024 Annual Report Card Award

Written by Customer Service on August 14, 2024. Posted in Public Companies.

Solution providers regard Tenable as the best in managed and cloud services and support COLUMBIA, Md., Aug. 14, 2024 (GLOBE NEWSWIRE) — Tenable®, the exposure management company, today announced it was named the top performer in cloud security in the 2024 CRN Annual Report Card Award from CRN®, a brand of The Channel Company. This award honors technology vendors for providing best-in-class products, partner program resources, partner support and managed and cloud services. “It is a great honor to be recognized by our partners as a trusted cloud security provider and this achievement is a testament to our collaborative commitment to joint customers,” said Jeff Brooks, senior vice president, Global Channels and Business Development, Tenable. “While ripe with business opportunity, the cloud opens organizations up to intense cyber...

Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System

Written by Customer Service on August 14, 2024. Posted in Public Companies.

Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and people Early detection potential has global pet and public health benefits SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory Board will also be joined by Boehringer Ingelheim, Mars Science & Diagnostics, and other leading pet, public health and...

INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA

Written by Customer Service on August 14, 2024. Posted in Earnings Releases And Operating Results.

SARASOTA, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment and acquisition of fertility clinics, and with the intravaginal culture (“IVC”) procedure enabled by its INVOcell® medical device, today announced financial results for the second quarter 2024 for the period ended June 30, 2024 and provided a business update. Q2 2024 Financial Highlights (all metrics compared to Q2 2023 unless otherwise noted) Revenue was $1,836,597, an increase of 481% compared to $315,902. Revenue increased 17% sequentially compared to Q1 2024. Clinic revenue increased 611% to $1,807,921, compared to $254,364. All reported clinic revenue is derived...

Crown Electrokinetics Reports Second Quarter 2024 Financial Results

Written by Customer Service on August 14, 2024. Posted in Earnings Releases And Operating Results.

Second Quarter Revenues of $4.6 million up from First Quarter Revenues of $0.7 million, an increase of 582% LOS ANGELES, Aug. 14, 2024 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in constructing fiber optic networks and lead pipe inspection and remediation, will report its financial results for the second quarter 2024 today, August 14, 2024. Doug Croxall, Crown CEO and Chairman, “Our second quarter represents our best revenue quarter in our history. As of today, we have eliminated all investment debt and all classes of our preferred equity; thereby cleaning up both our balance sheet and cap table significantly. We have added to our senior management team and announced two new lines of business with lead pipe inspection and remediation....

Kartoon Studios Provides Business Update for the Second Quarter of 2024; Key Metrics Up

Written by Customer Service on August 14, 2024. Posted in Earnings Releases And Operating Results.

BEVERLY HILLS, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — Kartoon Studios (NYSE American: TOON) today provided a business update for the quarter ended June 30, 2024. The Company’s Chairman & CEO, Andy Heyward, also provided a letter to shareholders, which is available HERE. Key Highlights Kartoon Channel! streaming service emerges as one of the premier kids’ entertainment hub; 120% growth in Amazon Prime subscribers from June 2023 to 2024; profitability of streaming services continues growing monthly Distribution across 16 platforms including iOS, Android Mobile, Web, Amazon Prime Video, Apple TV, Amazon Fire, Roku, Pluto TV, Comcast, Cox, Dish, Sling TV, Android TV, Tubi, Xumo, Samsung and LG Smart TVs; international presence, now operating in 69 countries globally, and growing Significant cost reductions across all...

Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Written by Customer Service on August 14, 2024. Posted in Earnings Releases And Operating Results.

Ongoing progress with both clinical trials of lead program, SON-1010, for solid tumors and Platinum-Resistant Ovarian Cancer (PROC) Partnership efforts to support initiation of a Phase 2 clinical trial of SON-080 in Diabetic Peripheral Neuropathy (DPN) underway Granted composition of matter patent in key territory – the United States – covering SON-1210 and its application in high-value solid tumor indications with significant unmet need, including pancreatic cancer Multiple value-driving milestones expected in 2024 and throughout 2025 as well as pipeline expansion opportunities throughout high-value solid tumor market PRINCETON, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today reported...

Day: August 14, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice